Impact of steatosis on insulin secretion in chronic hepatitis C patients

American Journal of Gastroenterology

Volumn 102, Issue 10, 2007, Pages 2173-2180

  Narita, Ryoichi ^a   Abe, Shintaro ^a   Tabaru, Akinari ^a   Otsuki, Makoto ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; HEPATITIS C, CHRONIC; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34848885256     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01443.x     Document Type: Article

References (37)

1. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis. Hepatology 1992 15 : 572 7.
2. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993 104 : 595 603.
3. Scheuer PJ, Ashrafzadeh P, Sherlock S, et al. The pathology of hepatitis C. Hepatology 1992 15 : 567 71.
4. Hui JM, Kench J, Farrell GC, et al. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection. J Gastroenterol Hepatol 2002 17 : 873 81.
5. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 37 : 917 23.
6. Scheen AJ, Luyckx FH. Nonalcoholic steatohepatitis and insulin resistance: Interface between gastroenterologists and endocrinologists. Acta Clin Belg 2003 58 : 81 91.
7. Barba G, Harper F, Harada T, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 1997 94 : 1200 5.
8. Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997 78 (Pt 7 1527 31.
9. Goto T, Onuma T, Takebe K, et al. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995 19 : 841 5.
10. Maruhama Y, Ohneda A, Tadaki H, et al. Hepatic steatosis and the elevated plasma insulin level in patients with endogenous hypertriglyceridemia. Metabolism 1975 24 : 653 64.
11. Chitturi S, Abeygunasekera S, Farrell GC, et al. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002 35 : 373 9.
12. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 2002 35 : 367 72.
13. Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998 114 : 842 5.
14. Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004 40 : 46 54.
15. Perumalswami P, Kleiner DE, Lutchman G, et al. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection. Hepatology 2006 43 : 780 7.
16. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001 33 : 1358 64.
17. Musso G, Gambino R, Biroli G, et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2005 100 : 2438 46.
18. Narita R, Abe S, Kihara Y, et al. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol 2004 41 : 132 8.
19. Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001 35 : 279 83.
20. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985 727 : 1 113.
21. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 9.
22. Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes 1977 26 : 944 52.
23. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000 23 : 295 301.
24. Scheuer PJ. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 1991 13 : 372 4.
25. Fabris P, Floreani A, Carlotto A, et al. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C. J Hepatol 2004 41 : 644 51.
26. Bruce R, Godsland I, Walton C, et al. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity. Metabolism 1994 43 : 1275 81.
27. Fartoux L, Poujol-Robert A, Guechot J, et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005 54 : 1003 8.
28. Kral JG, Schaffner F, Pierson RN, Jr., et al. Body fat topography as an independent predictor of fatty liver. Metabolism 1993 42 : 548 51.
29. Lee JH, Rhee PL, Lee JK, et al. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 1998 13 : 12 4.
30. Stromblad G, Bjorntorp P. Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 1986 35 : 323 7.
31. Ibrahim KM, Nicola WG, Salama SH. Mechanism of insulin resistance and hyper-insulinemia in fatty liver. Boll Chim Farm 1996 135 : 528 40.
32. Ikai E, Ishizaki M, Suzuki Y, et al. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J Hum Hypertens 1995 9 : 101 5.
33. Leandro G, Mangia A, Hui J. Steatosis is indepedently associated with fibrosis and necroinflammatory changes in chronic hepatitis C: A meta-analysis of individual patient data. Heaptology 2004 40 : 279.
34. Lee RG. Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler. Hepatology 1995 21 : 1742 3.
35. Paradis V, Dargere D, Vidaud M, et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999 30 : 968 76.
36. Paradis V, Perlemuter G, Bonvoust F, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 2001 34 : 738 44.
37. Svegliati-Baroni G, Ridolfi F, Di Sario A, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways. Hepatology 1999 29 : 1743 51.